Bill > A901

Introduced Session

This bill, to be known as "Max's Law," requires school districts to provide instruction on the dangers of fentanyl and xylazine as part of the district's implementation of the New Jersey Student Learning Standards in Comprehensive Health and Physical Education. Under the bill, the instruction is required to include information on: (1) fentanyl and xylazine abuse prevention; (2) fentanyl and xylazine poisoning awareness; (3) the dangers of synthetic opioids, including fentanyl or any substituted derivative of fentanyl, xylazine, and counterfeit drugs; (4) recognizing the symptoms of fentanyl and xylazine poisoning; (5) how to respond to a fentanyl or xylazine poisoning emergency; and (6) laws that provide immunity or other protections for persons who report drug or alcohol use, or who seek medical treatment for drug or alcohol poisoning or overdoses for themselves or others. Additionally, the bill requires the Commissioner of Education to provide school districts with age-appropriate resources designed to implement the requirements established under the bill. The information is required to utilize information and resources provided by: (1) the National Institutes of Health; (2) the United States Drug Enforcement Administration; (3) the United States Department of Health and Human Services; (4) the Centers for Disease Control and Prevention; or (5) any State, county, or municipal department or agency. The bill requires the Department of Education to post and maintain on its Internet website: (1) information for instruction on the dangers of fentanyl and xylazine provided to school districts; (2) informational materials containing awareness and safety information for school staff, students, and parents, on opioid poisoning prevention; (3) information on outreach organizations with resources concerning opioid awareness and opioid poisoning prevention; and (4) preventative mental health resources available from applicable federal, state, county, or municipal departments and agencies. Xylazine, commonly referred to as "tranq," is a non-opioid sedatitve, or tranquilizer. While xylazine is not considered a controlled substance in the United States, it is not approved for use in people. The Federal Drug Enforcement Administration reported that xylazine and fentanyl mixtures place users at a higher risk of suffering a fatal drug poisoning. It is the sponsor's intent that this bill raise awareness of the dangers of fentanyl and xylazine and to honor the memory of Max Lenowitz of Woodcliff Lake, a beloved son, brother, and friend, and the thousands of other New Jersey residents who have lost their lives to fentanyl or xylazine poisoning.

AI Summary

Committee Categories

John Azzariti (R)*,  Anthony Verrelli (D)*,  Bob Auth (R),  Al Barlas (R),  Chris DePhillips (R),  John DiMaio (R),  Kevin Egan (D),  Vicky Flynn (R),  Paul Kanitra (R),  Tennille McCoy (D),  Gregory Myhre (R),  Verlina Reynolds-Jackson (D),  William Sampson (D),  Alex Sauickie (R),  Gerry Scharfenberger (R),  Heather Simmons (D), 

Withdrawn Because Approved P.L.2025, c.278. (on 01/13/2026)

Official Document